Press Releases Investors Overview News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts Company Info Overview Management Team Clinical Advisory Board Medical Consultants Presentations Contacts FAQ Financial Info Overview Balance Sheet Income Statement Cash Flow Financial Results Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Overview Board of Directors Board Committees Governance Documents Investor Tools Email Alerts Tear Sheet Investor Presentation Contacts RSS News Feed News / Events Overview Press Releases Publications IR Calendar Analyst Coverage Email Alerts All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 All Releases Financial Releases Viveve(R) Announces FDA 510(k) Clearance for the Viveve System in the U.S. Oct 6, 2016 Viveve Submits Investigational Device Exemption (IDE) for VIVEVE II Sep 27, 2016 Viveve(R) to Present at Ladenburg Thalmann 2016 Healthcare Conference Sep 20, 2016 Viveve(R) Announces Resignation of Brigitte Smith From Company Board of Directors Sep 15, 2016 Viveve(R) Announces Distribution Agreement for Viveve System With Melon Ltd. in Finland Sep 15, 2016 Viveve(R) Announces Regulatory Approval for Viveve(R) System in Australia and Distribution Partnership with Device Consulting in Australia and New Zealand Sep 8, 2016 Viveve(R) to Present at Rodman & Renshaw 18th Annual Global Investment Conference Aug 25, 2016 Viveve(R) Reports Record Second Quarter Financial Results Aug 11, 2016 Viveve Announces Regulatory Approval for Viveve(R) System in Singapore Aug 9, 2016 Viveve Announces Regulatory Approval for Viveve(R) System in South Korea Aug 4, 2016 1... 12 13 14 15 16 17 18 19 20 21 ...32
Viveve(R) Announces Regulatory Approval for Viveve(R) System in Australia and Distribution Partnership with Device Consulting in Australia and New Zealand Sep 8, 2016
